influenza vaccine

Also found in: Encyclopedia, Wikipedia.

influenza vaccine (nasal)

(in-floo-en-za vak-seen) ,


(trade name)


Therapeutic: vaccines immunizing agents
Pregnancy Category: C


Active live immunization for prevention of disease caused by Influenza A and B.


Active immunization with live virus produces antibodies against Influenza.

Therapeutic effects

Decreased influenzal illness, with fewer days lost from school or work.


Absorption: Virus replicates in nasopharynx causing production of antibodies.
Distribution: Unknown.
Metabolism and Excretion: Unknown.
Half-life: Unknown.

Time/action profile



Contraindicated in: Obstetric: Pregnancy; Hypersensitivity to FluMist, eggs, or egg products; History of asthma or reactive airways disease; Other live vaccine within 1 mo or inactivated vaccine within 2 weeks; Concurrent immunosuppressive therapy or disease causing immunosuppression or immunocompromise; Antiviral agents (not for 48 hr prior or 2 wk after); Pediatric: Children or adolescents (5–17 yr) receiving aspirin, aspirin-containing or salicylate therapy (risk of Reye syndrome); Chronic illness including cardiac/pulmonary disease, metabolic disease, renal impairment or hemoglobinopathy; History of Guillain-Barré.
Use Cautiously in: Obstetric / Pediatric: Lactation, children <2 yr, patients >50 yr (safety not established).

Adverse Reactions/Side Effects

Central nervous system

  • headache

Ear, Eye, Nose, Throat

  • rhinitis
  • nasal congestion


  • fever


Drug-Drug interaction

Concurrent use of aspirin or salicylates in children/adolescents may ↑ risk of Reye syndrome.Concurrent antiviral therapy (may affect desired immune response to FluMist).


Intranasal (Adults and Children 9–49 yr) One dose (0.5 mL)/season.
Intranasal (Children 2–8 yr) Previously immunized with FluMist—one dose (0.2 mL)/season; not previously immunized with FluMist—two doses (0.2 mL each)/30 days apart for initial season.


Pre-filled single-use intranasal sprayer: 0.5 mL/sprayer, 0.2 mL/sprayer

Nursing implications

Nursing assessment

  • Assess patient for history of asthma or reactive airway disease. Patients with positive history should not receive FluMist.
  • Lab Test Considerations: Monitor patient for signs of allergic reaction (rash, pruritus, laryngeal edema, wheezing) following administration. Keep epinephrine, an antihistamine, and resuscitation equipment close by in case of an anaphylactic reaction.

Potential Nursing Diagnoses

Deficient knowledge, related to medication regimen (Patient/Family Teaching)


  • Do not administer rimantidine or other antiviral agents within 48 hrs before or 2 wks after administration intranasal influenza virus vaccine (FluMist).
  • Store solution in refrigerator until just before use; do not freeze. Solution should be colorless to pale yellow and clear to slightly cloudy.
    • Do not administer FluMist concurrently with other vaccines, or in patients who have received a live virus vaccine within 1 mo or an inactivated vaccine within 2 wks of vaccination.
  • Intranasal: With the patient in an upright position, approximately 0.25 mL (half the dose of a single FluMist sprayer) is administered into each nostril. Insert the tip of the sprayer just inside the nostril and depress the plunger to spray. Remove the dose divider clip and administer the second half of the dose into the other nostril. Dispose of sprayer in routine for biohazard disposal.

Patient/Family Teaching

  • Explain to patient and parent the purpose of the vaccination.
  • Advise patient to avoid contact with patients who are immunocompromised for at least 21 days.

Evaluation/Desired Outcomes

  • Prevention of influenza resulting in fewer lost days from work and school.

influenza vaccine

Flu vaccine A vaccine recommended for those at high risk for serious complications from influenza: > age 65; Pts with chronic diseases of heart, lung or kidneys, DM, immunosuppression, severe anemia, nursing home and other chronic-care residents, children and teenagers taking aspirin therapy–and who may thus be at risk for developing Reye syndrome after influenza infection, and those in close or frequent contact with anyone at high risk; persons with egg allergy should not receive IV. See Influenza, Vaccine.
References in periodicals archive ?
3,4) While hospitalization rates are higher for infants aged 0 to 5 months, influenza vaccine is not approved for use in this age group.
While influenza vaccines can cause arm soreness and a little achiness, they don't cause colds or flu, Nagami said.
M2 PHARMA-February 2, 2017-Seasonal Influenza Vaccines Drug Market to Reach USD 4.
The Advisory Committee on Immunization Practices of US Centers for Disease Control and Prevention has recommended not to use live attenuated influenza vaccine, called 'nasal spray' flu vaccine, during the 2016-2017 flu season, it was reported on Friday.
Advances in influenza virology, immunology and vaccinology make the development of a universal influenza vaccine more feasible than a decade ago, according to the authors.
The traditional seasonal influenza vaccine is a trivalent formula consisting of two strains of influenza A virus and a single strain of influenza B virus.
PharmaJet Inc reported on Tuesday the start of shipment of the quadrivalent and trivalent influenza vaccine for needle-free delivery for the 2017-18 influenza season.
Flublok is the only recombinant protein-based influenza vaccine approved by the US Food and Drug Administration.
In West Virginia, for example, a state where 38% of the population resides in rural areas, people who were insured by Medicare and whose insurance records did not manifest that they received the influenza vaccine, possessed a 170% increased risk of death during the influenza season in comparison to those who did receive the influenza vaccine (Schade & McCombs, 2000).
The clinic I work in asks all patients if they have allergy to eggs before giving the influenza vaccine.
Influenza vaccines contain either 3 or 4 antigens (trivalent or quadrivalent) and either inactivated or modified live viruses (inactivated influenza vaccine [IIV]) or live attenuated influenza vaccine [LAIV]).